Glucosidase inhibitors induce HCV glycoproteins misfolding, impair viral assembly and release, and reduce the infectivity of residually secreted HCV particles
Novel anti-HCV molecules are still needed to better combat HCV infection. Molecules targeting specifically viral activities are the most attractive in terms of drug development and are therefore the most studied. The antiviral properties of glucosidase inhibitors were established using the most rele...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Conference item |
| Published: |
Wiley
2006
|
| _version_ | 1797054644796522496 |
|---|---|
| author | Chapel, C Garcia, C Bartosch, B Roingeard, P Zitzmann, N Cosset, F Dubuisson, J Dwek, R Trepo, C Zoulim, F Durantel, D |
| author_facet | Chapel, C Garcia, C Bartosch, B Roingeard, P Zitzmann, N Cosset, F Dubuisson, J Dwek, R Trepo, C Zoulim, F Durantel, D |
| author_sort | Chapel, C |
| collection | OXFORD |
| description | Novel anti-HCV molecules are still needed to better combat HCV infection. Molecules targeting specifically viral activities are the most attractive in terms of drug development and are therefore the most studied. The antiviral properties of glucosidase inhibitors were established using the most relevant models currently available. |
| first_indexed | 2024-03-06T19:00:07Z |
| format | Conference item |
| id | oxford-uuid:133cb2f7-ea3e-422a-b547-5b1491b7c587 |
| institution | University of Oxford |
| last_indexed | 2024-03-06T19:00:07Z |
| publishDate | 2006 |
| publisher | Wiley |
| record_format | dspace |
| spelling | oxford-uuid:133cb2f7-ea3e-422a-b547-5b1491b7c5872022-03-26T10:12:45ZGlucosidase inhibitors induce HCV glycoproteins misfolding, impair viral assembly and release, and reduce the infectivity of residually secreted HCV particlesConference itemhttp://purl.org/coar/resource_type/c_5794uuid:133cb2f7-ea3e-422a-b547-5b1491b7c587Symplectic Elements at OxfordWiley2006Chapel, CGarcia, CBartosch, BRoingeard, PZitzmann, NCosset, FDubuisson, JDwek, RTrepo, CZoulim, FDurantel, DNovel anti-HCV molecules are still needed to better combat HCV infection. Molecules targeting specifically viral activities are the most attractive in terms of drug development and are therefore the most studied. The antiviral properties of glucosidase inhibitors were established using the most relevant models currently available. |
| spellingShingle | Chapel, C Garcia, C Bartosch, B Roingeard, P Zitzmann, N Cosset, F Dubuisson, J Dwek, R Trepo, C Zoulim, F Durantel, D Glucosidase inhibitors induce HCV glycoproteins misfolding, impair viral assembly and release, and reduce the infectivity of residually secreted HCV particles |
| title | Glucosidase inhibitors induce HCV glycoproteins misfolding, impair viral assembly and release, and reduce the infectivity of residually secreted HCV particles |
| title_full | Glucosidase inhibitors induce HCV glycoproteins misfolding, impair viral assembly and release, and reduce the infectivity of residually secreted HCV particles |
| title_fullStr | Glucosidase inhibitors induce HCV glycoproteins misfolding, impair viral assembly and release, and reduce the infectivity of residually secreted HCV particles |
| title_full_unstemmed | Glucosidase inhibitors induce HCV glycoproteins misfolding, impair viral assembly and release, and reduce the infectivity of residually secreted HCV particles |
| title_short | Glucosidase inhibitors induce HCV glycoproteins misfolding, impair viral assembly and release, and reduce the infectivity of residually secreted HCV particles |
| title_sort | glucosidase inhibitors induce hcv glycoproteins misfolding impair viral assembly and release and reduce the infectivity of residually secreted hcv particles |
| work_keys_str_mv | AT chapelc glucosidaseinhibitorsinducehcvglycoproteinsmisfoldingimpairviralassemblyandreleaseandreducetheinfectivityofresiduallysecretedhcvparticles AT garciac glucosidaseinhibitorsinducehcvglycoproteinsmisfoldingimpairviralassemblyandreleaseandreducetheinfectivityofresiduallysecretedhcvparticles AT bartoschb glucosidaseinhibitorsinducehcvglycoproteinsmisfoldingimpairviralassemblyandreleaseandreducetheinfectivityofresiduallysecretedhcvparticles AT roingeardp glucosidaseinhibitorsinducehcvglycoproteinsmisfoldingimpairviralassemblyandreleaseandreducetheinfectivityofresiduallysecretedhcvparticles AT zitzmannn glucosidaseinhibitorsinducehcvglycoproteinsmisfoldingimpairviralassemblyandreleaseandreducetheinfectivityofresiduallysecretedhcvparticles AT cossetf glucosidaseinhibitorsinducehcvglycoproteinsmisfoldingimpairviralassemblyandreleaseandreducetheinfectivityofresiduallysecretedhcvparticles AT dubuissonj glucosidaseinhibitorsinducehcvglycoproteinsmisfoldingimpairviralassemblyandreleaseandreducetheinfectivityofresiduallysecretedhcvparticles AT dwekr glucosidaseinhibitorsinducehcvglycoproteinsmisfoldingimpairviralassemblyandreleaseandreducetheinfectivityofresiduallysecretedhcvparticles AT trepoc glucosidaseinhibitorsinducehcvglycoproteinsmisfoldingimpairviralassemblyandreleaseandreducetheinfectivityofresiduallysecretedhcvparticles AT zoulimf glucosidaseinhibitorsinducehcvglycoproteinsmisfoldingimpairviralassemblyandreleaseandreducetheinfectivityofresiduallysecretedhcvparticles AT duranteld glucosidaseinhibitorsinducehcvglycoproteinsmisfoldingimpairviralassemblyandreleaseandreducetheinfectivityofresiduallysecretedhcvparticles |